Prof. Dr. med. Matthias Heck
Lehrstuhlinhaber
Urologie
| Telefon: | +49 (0)821 400-2870 |
| E-Mail: | matthias.heck@uk-augsburguk-augsburg.de () |
| Adresse: | Stenglinstraße 2, 86156 Augsburg |
Zur Person
Publikationen
2025
|
2024
|
2023
|
2022
|
2021
|
2025 |
|
Gabler N., Kirchhoff S., Sauter A., Heck Matthias, Lorenzini T., Haller B., Weber W., Eiber M., Rauscher I..
18F-Flotufolastat PET/MR in suspicious prostate cancer: correlation with histopathological biopsy-results [Abstract].
https://doi.org/10.1055/s-0045-1804322
BibTeX | RIS | DOI |
|
Knipper Sophie, Lischewsk Flemming, Koehler Daniel, Eiber Matthias, van Leeuwen Fijs W. B., de Barros Hilda, Berrens Anne-Claire, Zuur Lotte, van Leeuwen Pim J., van der Poel Henk, Ambrosini Francesca, Falkenbach Fabian, Budäus Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Gschwend Jürgen E., Horn Thomas, Heck Matthias M., Maurer Tobias.
Biochemical response of <0.1 ng/ml predicts therapy-free survival of prostate cancer patients following prostate-specific membrane antigen–targeted salvage surgery.
https://doi.org/10.1016/j.euo.2024.04.019
PDF | BibTeX | RIS | DOI |
|
Karimzadeh A., Fütterer C., Hansen K., Heck Matthias, Tauber R., D'Alessandria C., Weber W., Eiber M., Rauscher I..
External validation of baseline 68Ga-PSMA-11 PET-based prediction models using 18F-flotufolastat PET in patients with metastatic castration-resistant prostate cancer receiving 177Lu-labeled PSMA-targeted radioligand therapy [Abstract].
https://doi.org/10.1055/s-0045-1804353
BibTeX | RIS | DOI |
|
Gammel M., Olufs C., Brosch-Lenz J., Heck Matthias, Weber W., Eiber M., Rauscher I..
Insights into renal split function assessment via PSMA-ligand PET/CT [Abstract].
https://doi.org/10.1055/s-0045-1804376
BibTeX | RIS | DOI |
|
Schweiger Lilit, Maurer Tobias, Simon Ricarda, Horn Thomas, Heck Matthias M., Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Pattern of failure in patients with biochemical recurrence after PSMA radioguided surgery.
https://doi.org/10.2967/jnumed.124.268151
BibTeX | RIS | DOI |
|
Karimzadeh Amir, Hansen Kimberley, Hasa Ergela, Haller Bernhard, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.1007/s00259-024-07003-2
PDF | BibTeX | RIS | DOI |
|
Falkenbach Fabian, Lischewski Flemming, Knipper Sophie, Koehler Daniel, Karakiewicz Pierre I., Tian Zhe, Saad Fred, Tilki Derya, Budäus Lars, Steuber Thomas, Mandel Philipp, Wenzel Mike, Gschwend Jürgen E., Graefen Markus, Heck Matthias M., Maurer Tobias.
Prostate-specific membrane antigen–radioguided surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment.
https://doi.org/10.1016/j.euf.2025.01.006
BibTeX | RIS | DOI |
|
2024 |
|
Karimzadeh Amir, Hecker Charlotte-Sophie, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval.
https://doi.org/10.1186/s13550-024-01143-0
PDF | BibTeX | RIS | DOI |
|
2023 |
|
Knipper S., Lischewski F., Koehler D., Eiber M., Van Leeuwen F. W. B., De Barros H., Berrens A., Van Leeuwen P., Van Der Poel H., Falkenbach F., Budäus L., Steuber T., Graefen M., Gschwend J. E., Tennstedt P., Horn T., Heck Matthias M., Maurer T..
A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
https://doi.org/10.1016/s0302-2838(23)01160-0
BibTeX | RIS | DOI |
|
Knipper S., Lischewski F., Koehler D., Eiber M., van Leeuwen F. W. B., de Barros H., Berrens A. C., van Leeuwen P., van der Poel H., Ambrosini F., Falkenbach F., Budäus L., Steuber T., Graefen M., Tennstedt P., Gschwend J. E., Horn T., Heck Matthias M., Maurer T..
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of prostate cancer patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
https://doi.org/10.1016/s2666-1683(23)01298-3
PDF | BibTeX | RIS | DOI |
|
Muehlematter Urs J., Schweiger Lilit, Ferraro Daniela A., Hermanns Thomas, Maurer Tobias, Heck Matthias M., Rupp Niels J., Eiber Matthias, Rauscher Isabel, Burger Irene A..
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
https://doi.org/10.1007/s00259-023-06278-1
PDF | BibTeX | RIS | DOI |
|
Falkenbach Fabian, Ambrosini Francesca, Tennstedt Pierre, Eiber Matthias, Heck Matthias M., Preisser Felix, Graefen Markus, Budäus Lars, Koehler Daniel, Knipper Sophie, Maurer Tobias.
EAU biochemical recurrence risk classification and PSA kinetics have no value for patient selection in PSMA-radioguided surgery (PSMA-RGS) for oligorecurrent prostate cancer.
https://doi.org/10.3390/cancers15205008
PDF | BibTeX | RIS | DOI |
|
Spohn Simon K. B., Draulans Cédric, Kishan Amar U., Spratt Daniel, Ross Ashley, Maurer Tobias, Tilki Derya, Berlin Alejandro, Blanchard Pierre, Collins Sean, Bronsert Peter, Chen Ronald, Dal Pra Alan, de Meerleer Gert, Eade Thomas, Haustermans Karin, Hölscher Tobias, Höcht Stefan, Ghadjar Pirus, Davicioni Elai, Heck Matthias M., Kerkmeijer Linda G. W., Kirste Simon, Tselis Nikolaos, Tran Phuoc T., Pinkawa Michael, Pommier Pascal, Deltas Constantinos, Schmidt-Hegemann Nina-Sophie, Wiegel Thomas, Zilli Thomas, Tree Alison C., Qiu Xuefeng, Murthy Vedang, Epstein Jonathan I., Graztke Christian, Gao Xin, Grosu Anca L., Kamran Sophia C., Zamboglou Constantinos.
Genomic classifiers in personalized prostate cancer radiation therapy approaches: a systematic review and future perspectives based on international consensus.
https://doi.org/10.1016/j.ijrobp.2022.12.038
PDF | BibTeX | RIS | DOI |
|
Groeben Christer, Boehm Katharina, Koch Rainer, Sonntag Ulrich, Nestler Tim, Struck Julian, Heck Matthias, Baunacke Martin, Uhlig Annemarie, Koelker Mara, Meyer Christian P., Becker Benedikt, Salem Johannes, Huber Johannes, Leitsmann Marianne.
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study.
https://doi.org/10.1007/s00345-022-04271-1
PDF | BibTeX | RIS | DOI |
|
Hekimsoy T., Heck Matthias M., Gschwend J. E., Schwamborn K., Eiber M., Weber W..
How many unnecessary prostate biopsies can be avoided by PSMA PET/MR? [Abstract].
https://doi.org/10.1055/s-0043-1766180
BibTeX | RIS | DOI |
|
Karimzadeh A., Soeiro P., Feuerecker B., Heck Matthias M., Tauber R., Knorr K., D'Alessandria C., Weber W., Eiber M., Rauscher I..
Improved quality of life in mCRPC patients receiving consecutive cycles of 177Lu-PSMA RLT [Abstract].
https://doi.org/10.1055/s-0043-1766217
BibTeX | RIS | DOI |
|
Karimzadeh Amir, Soeiro Paula, Feuerecker Benedikt, Hecker Charlotte-Sophie, Knorr Karina, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang, Eiber Matthias, Rauscher Isabel.
Improved quality of life in metastatic castration-resistant prostate cancer patients receiving consecutive cycles of 177Lu-PSMA I&T.
https://doi.org/10.2967/jnumed.123.265878
BibTeX | RIS | DOI |
|
Jahnen Matthias, Heck Matthias M..
Kommentar zu: Radikale Prostatektomie beim oligometastasierten Prostatakarzinom.
https://doi.org/10.1055/a-2060-4417
BibTeX | RIS | DOI |
|
Ambrosini Francesca, Falkenbach Fabian, Budäus Lars, Graefen Markus, Koehler Daniel, Lischewski Flemming, Gschwend Juergen E., Heck Matthias M., Eiber Matthias, Knipper Sophie, Maurer Tobias.
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer.
https://doi.org/10.23736/s2724-6051.23.05445-9
BibTeX | RIS | DOI |
|
Meagher Margaret F., Mir Maria C., Minervini Andrea, Kriegmair Maximilian, Heck Matthias M., Porpiglia Francesco, Van Bruwaene Siska, Linares Estefania, Hevia Vital, D'Anna Maurizio, Veccia Alessandro, Roussel Eduard, Claps Francesco, Palumbo Carlotta, Marchioni Michele, Afari Jonathan, Saitta Cesare, Liu Franklin, Rubio Jose, Campi Riccardo, Mari Andrea, Amiel Thomas, Checcucci Enrico, Musquera Mireia, Guruli Georgi, Pavan Nicola, Albersen Maarten, Antonelli Alessandro, Klatte Tobias, Autorino Riccardo, McKay Rana R., Derweesh Ithaar H..
Proposal for a two-tier re-classification of stage IV/M1 domain of renal cell carcinoma into M1 ("oligometastatic") and M2 ("polymetastatic") subdomains: analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
https://doi.org/10.3389/fonc.2023.1113246
PDF | BibTeX | RIS | DOI |
|
Lunger Lukas, Steinhelfer Lisa, Korn Philipp, Eiber Matthias, Maurer Tobias, Büchler Jakob, Horn Thomas, Gschwend Jürgen E., Heck Matthias M..
Prostate-specific membrane antigen–radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases.
https://doi.org/10.1016/j.euo.2022.12.001
BibTeX | RIS | DOI |
|
Falkenbach Fabian, Knipper Sophie, Koehler Daniel, Ambrosini Francesca, Steuber Thomas, Graefen Markus, Budäus Lars, Eiber Matthias, Lunger Lukas, Lischewski Flemming, Heck Matthias M., Maurer Tobias.
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
https://doi.org/10.1007/s00345-023-04534-5
PDF | BibTeX | RIS | DOI |
|
Seifert Robert, Emmett Louise, Rowe Steven P., Herrmann Ken, Hadaschik Boris, Calais Jeremie, Giesel Frederik L., Reiter Robert, Maurer Tobias, Heck Matthias M., Gafita Andrei, Morris Michael J., Fanti Stefano, Weber Wolfgang A., Hope Thomas A., Hofman Michael S., Fendler Wolfgang Peter, Eiber Matthias.
Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2).
https://doi.org/10.1016/j.eururo.2023.02.002
PDF | BibTeX | RIS | DOI |
|
Karimzadeh Amir, Heck Matthias M., Tauber Robert, Solaris Esteban, Nekolla Stephan, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
The impact of PSMA PET–based eligibility criteria used in the prospective phase II TheraP trial in metastatic castration-resistant prostate cancer patients undergoing prostate-specific membrane antigen–targeted radioligand therapy.
https://doi.org/10.2967/jnumed.122.265346
BibTeX | RIS | DOI |
|
Lunger Lukas, Eiber Matthias, Heck Matthias M..
Theranostik.
https://doi.org/10.1007/978-3-662-67297-6_9
BibTeX | RIS | DOI |
|
Herms Elena, Weirich Gregor, Maurer Tobias, Wagenpfeil Stefan, Preuss Stephanie, Sauter Andreas, Heck Matthias, Gärtner Anita, Hauner Katharina, Autenrieth Michael, Kübler Hubert P., Holzapfel Konstantin, Schwarz-Boeger Ulrike, Heemann Uwe, Slotta-Huspenina Julia, Stock Konrad Friedrich.
Ultrasound-based "CEUS-Bosniak" classification for cystic renal lesions: an 8-year clinical experience.
https://doi.org/10.1007/s00345-022-04094-0
BibTeX | RIS | DOI |
|
2022 |
|
Babst Christa, Amiel Thomas, Maurer Tobias, Knipper Sophie, Lunger Lukas, Tauber Robert, Retz Margitta, Herkommer Kathleen, Eiber Matthias, von Amsberg Gunhild, Graefen Markus, Gschwend Juergen, Steuber Thomas, Heck Matthias.
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer.
https://doi.org/10.1016/j.ajur.2021.04.003
BibTeX | RIS | DOI |
|
Harke Nina N., Wagner Christian, Hermann Robert M., Hadaschik Boris A., Radtke Jan Philipp, Altay-Langguth Alev, Aufderklamm Stefan, Bach Christian, Becker-Schiebe Martina, Blana Andreas, Bruns Frank, Buse Stephan, Combs Stephanie E., Engels Christina L., Ezzibdeh Emad, Fiedler Marcel, Fischer Laura-Anna, Farzat Mahmoud, Frismann Alexander, Heck Matthias M., Henkenberens Christoph, Roesch Marie C., Käding Christoph, Klautke Gunther, Krausewitz Philipp, Kuczyk Markus A., Leitsmann Conrad, Lettmaier Sebastian, Mahjoub Samy, Manseck Andreas, Medenwald Daniel, Meyer Andreas, Micke Oliver, Moritz Rudolf, Ott Marcel, Peters Inga, Pokupic Sasa, Porres Daniel, Preisser Felix, Reichel Kathrin, Schneider Andreas, Schwentner Christian, Scobioala Sergiu, Truss Michael, Wegener Daniel, Wezel Felix, Willborn Kay, Witt Jörn H., Wittig Andrea, Wittlinger Michael, Wolff Hendrik A., Zimmermanns Volker, Christiansen Hans.
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: a German survey on prostate cancer diagnosis and treatment.
https://doi.org/10.1371/journal.pone.0269827
BibTeX | RIS | DOI |
|
2021 |
|
Lunger Lukas, Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, Jäger Marion, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Koll Florestan, Gschwend Jürgen E., Nawroth Roman, Heck Matthias M..
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
https://doi.org/10.1038/s41391-020-00283-3
BibTeX | RIS | DOI |
|
Lunger Lukas, Tauber Robert, Feuerecker Benedikt, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M..
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.21037/tau-20-1135
BibTeX | RIS | DOI |